Up-Front Endoscopy Maximizes Cost-Effectiveness and Cost-Satisfaction in Uninvestigated Dyspepsia
Clinical Gastroenterology and Hepatology · 2023-08 · 21 (9) · 2378-2388.e28
DOI: 10.1016/j.cgh.2023.01.003 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-08. Verfasst von Emily V Wechsler und 11 weiteren Autor:innen. Beteiligte Einrichtung: Geisel School of Medicine, Hanover, New Hampshire; Section of Gastroenterology and Hepatology, Dartmouth Health, Lebanon, New Hampshire. Hauptthemen laut MEDLINE: Dyspepsia, Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND & AIMS: Practice guidelines promote a routine noninvasive, non-endoscopic initial approach to investigating dyspepsia without alarm features in young patients, yet many patients undergo prompt upper endoscopy. We aimed to assess tradeoffs among costs, patient satisfaction, and clinical outcomes to inform discrepancy between guidelines and practice. METHODS: We constructed a decision-analytic model and performed cost-effectiveness/cost-satisfaction analysis over a 1-year time horizon on patients with uninvestigated dyspepsia without alarm features referred to gastroenterology. A RAND/UCLA expert panel informed model design. Four competing diagnostic/management strategies were evaluated: prompt endoscopy, testing for Helicobacter pylori and eradicating if present (test-and-treat), testing for H pylori and performing endoscopy if present (test-and-scope), and empiric acid suppression. Outcomes were derived from systematic reviews of clinical trials. Costs were informed by prospective observational cohort studies and national commercial/federal cost databases. Health gains were represented using quality-adjusted life years. RESULTS: From the patient perspective, costs and outcomes were similar for all strategies (maximum out-of-pocket difference of $30 and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Geisel School of Medicine, Hanover, New Hampshire; Section of Gastroenterology and Hepatology, Dartmouth Health, Lebanon, New Hampshire.
- Division of Gastroenterology, Penn Medicine, Philadelphia, Pennsylvania.
- Division of Gastroenterology, Northwestern Medicine, Chicago, Illinois.
- Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts.
- Division of Gastroenterology, University of California Los Angeles, Los Angeles, California.
- Division of Gastroenterology, Michigan Medicine, Ann Arbor, Michigan.
Förderung
- CSRD VA
- NIDDK NIH HHS
Zitieren
APA
Wechsler, E. V., Ahuja, N. K., Brenner, D., Chan, W., Chang, L., Chey, W. D., Lembo, A. J., Moshiree, B., Nee, J., Shah, S. C., Staller, K., & Shah, E. D. (2023). Up-Front Endoscopy Maximizes Cost-Effectiveness and Cost-Satisfaction in Uninvestigated Dyspepsia. Clinical Gastroenterology and Hepatology, 21(9), 2378-2388.e28. https://doi.org/10.1016/j.cgh.2023.01.003
Vancouver
Wechsler EV, Ahuja NK, Brenner D, Chan W, Chang L, Chey WD, et al. Up-Front Endoscopy Maximizes Cost-Effectiveness and Cost-Satisfaction in Uninvestigated Dyspepsia. Clinical Gastroenterology and Hepatology. 2023;21(9):2378-2388.e28. doi:10.1016/j.cgh.2023.01.003
BibTeX
@article{Wechsler2023,
author = {Wechsler, Emily V and Ahuja, Nitin K and Brenner, Darren and Chan, Walter and Chang, Lin and Chey, William D and Lembo, Anthony J and Moshiree, Baha and Nee, Judy and Shah, Shailja C and Staller, Kyle and Shah, Eric D},
title = {Up-Front Endoscopy Maximizes Cost-Effectiveness and Cost-Satisfaction in Uninvestigated Dyspepsia},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
volume = {21},
number = {9},
pages = {2378--2388.e28},
doi = {10.1016/j.cgh.2023.01.003}
}
EUVIMED